Kymera Therapeutics (KYMR)
(Delayed Data from NSDQ)
$33.35 USD
-1.86 (-5.28%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $33.38 +0.03 (0.09%) 6:04 PM ET
2-Buy of 5 2
F Value B Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/02/2024
Time: -- |
3/2024 | $-0.73 | 3.78% |
Earnings Summary
For their last quarter, Kymera Therapeutics (KYMR) reported earnings of -$0.25 per share, beating the Zacks Consensus Estimate of $-0.44 per share. This reflects a positive earnings surprise of 43.18%. Look out for KYMR's next earnings release expected on May 02, 2024. For the next earning release, we expect the company to report earnings of -$0.73 per share, reflecting a year-over-year decrease of 4.29%.
Earnings History
Price & Consensus
Zacks News for KYMR
Repare Therapeutics Inc. (RPTX) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
KYMR: What are Zacks experts saying now?
Zacks Private Portfolio Services